Trial Outcomes & Findings for Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution (NCT NCT03326323)
NCT ID: NCT03326323
Last Updated: 2020-01-13
Results Overview
Time it takes (hours) for platelet function to recover post-ANH to pre-procedure levels as measured by platelet aggregation.
Recruitment status
COMPLETED
Target enrollment
43 participants
Primary outcome timeframe
Baseline through 24 hours post ANH procedure
Results posted on
2020-01-13
Participant Flow
Participant milestones
| Measure |
Patients Undergoing ANH During CABG
Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.
|
|---|---|
|
Overall Study
STARTED
|
43
|
|
Overall Study
COMPLETED
|
40
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
Patients Undergoing ANH During CABG
Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.
|
|---|---|
|
Overall Study
Unable to receive ANH protocol
|
3
|
Baseline Characteristics
Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
Baseline characteristics by cohort
| Measure |
Patients Undergoing ANH During CABG
n=43 Participants
Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.
|
|---|---|
|
Age, Continuous
|
66 years
STANDARD_DEVIATION 10 • n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
38 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
6 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
30 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
43 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline through 24 hours post ANH procedureTime it takes (hours) for platelet function to recover post-ANH to pre-procedure levels as measured by platelet aggregation.
Outcome measures
| Measure |
Patients Undergoing ANH During CABG
n=40 Participants
Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.
|
|---|---|
|
Recovery in Platelet Function Post ANH
|
2 hours
Standard Deviation 30
|
SECONDARY outcome
Timeframe: Baseline through 24 hours post ANH procedureTime it takes for Mean Clot Firmness (MCF) to return normal levels post-ANH as measured by ROTEM
Outcome measures
| Measure |
Patients Undergoing ANH During CABG
n=40 Participants
Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.
|
|---|---|
|
Recovery in Mean Clot Firmness Post ANH
|
18 hours
Standard Deviation 6
|
Adverse Events
Patients Undergoing ANH During CABG
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place